The ex vivo immunohistochemistry (IHC) analysis of CD31 staining, an endothelial cell marker, cross‐validated this finding, as the ER‐ tumours showed significantly greater CD31 positivity (P < 0.05, Figure 5c). Here, PECAM1 is linked to neoplasm.